At one time, when generalized anxiety disorder was a nonspecific disorder characterized by diffuse anxiety symptoms, the use of HAM-A was appropriate. However, with the introduction of DSM-III-R in 1987, generalized anxiety disorder became a disorder of worry. The central symptom of DSM-IV-TR-defined generalized anxiety disorder is excessive and uncontrollable worry. HAM-A does not adequately measure the central symptom of DSM-IV-TR generalized anxiety disorder (2). Furthermore, most of the symptoms assessed by HAM-A (e.g., cardiovascular, respiratory, and gastrointestinal symptoms) are not among the DSM-IV-TR-associated symptoms of generalized anxiety disorder. HAM-A has been in existence for one-half century and remains a popular instrument for assessing anxiety despite these limitations. However, the scale is poor at discriminating between generalized anxiety disorder and depression (3), and there are several newer measures that are more appropriate for assessing generalized anxiety disorder symptoms and worry in particular. Of note, in the randomized, controlled trial conducted by Leichsenring et al., short-term psychodynamic psychotherapy and CBT led to comparable decreases in HAM-A scores. However, CBT was superior to short-term psychodynamic psychotherapy in the secondary outcome measure, which was the Penn State Worry Questionnaire, a well-established measure of excessive and uncontrollable worry.